Rianlon Corporation (300596.SZ) plans to acquire a minority stake in its subsidiary.
Lianlong (300596.SZ) announced that, in order to further strengthen the management level of its controlling subsidiaries and enhance decision-making efficiency, the company plans to acquire 30% equity stake in Lianlong Kerun (Zhejiang) New Materials Co., Ltd. ("Lianlong Kerun") in cash, with a transaction price of 78 million RMB. After the transaction is completed, the company's holding in Lianlong Kerun will increase from 70% to 100%, and there will be no change in the company's consolidated financial statements scope.
Rianlon Corporation (300596.SZ) announced that in order to further strengthen the management level of its controlling subsidiaries and improve decision-making efficiency, the company plans to acquire 30% equity of Rianlon Corporation Kern (Zhejiang) New Materials Co., Ltd (referred to as "Rianlon Corporation Kern") in cash for a transaction price of 78 million yuan. After the transaction is completed, the company's ownership of Rianlon Corporation Kern will increase from 70% to 100%, and there will be no change in the company's consolidated financial statements.
The company also plans to acquire 31.2644% equity of Rianlon Corporation (Inner Mongolia) New Materials Co., Ltd (referred to as "Rianlon Corporation Chifeng") in cash for a consideration of 68.78146 million yuan. After this transaction is completed, the company's ownership of Rianlon Corporation Chifeng will increase from 53.7356% to 85%, and there will be no change in the company's consolidated financial statements.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th






